Author:
Currow David,Ferreira Diana
Publisher
Springer International Publishing
Reference85 articles.
1. Abdallah SJ, Faull OK, Wanigasekera V, et al. Opioids for breathlessness: psychological and neural factors influencing response variability. Eur Respir J. 2019;54(3):1900275.
2. Abernethy AP, McDonald CF, Frith PA, Clark K, Herndon JE, Marcello J, Young IH, Bull J, Wilcock A, Booth S, Wheeler JL. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet. 2010;376(9743):784–93.
3. Allard P, Lamontagne C, Bernard P, Tremblay C. How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. J Pain Symptom Manag. 1999;17(4):256–65.
4. Austroads. Assessing fitness to drive for commercial and private vehicle drivers – 2022 edition. https://austroads.com.au/__data/assets/pdf_file/0037/498691/AP-G56-22_Assessing_Fitness_Drive.pdf. Accessed 30 Nov 2022.
5. Banzett RB, Mulnier HE, Murphy K, Rosen SD, Wise RJ, Adams L. Breathlessness in humans activates insular cortex. Neuroreport. 2000;11(10):2117–20.